97 related articles for article (PubMed ID: 8335396)
1. Intravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas.
Bamias A; Bowles MJ; Krausz T; Williams G; Epenetos AA
Int J Cancer; 1993 Jul; 54(6):899-903. PubMed ID: 8335396
[TBL] [Abstract][Full Text] [Related]
2. Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma.
Bamias A; Keane P; Krausz T; Williams G; Epenetos AA
Cancer Res; 1991 Jan; 51(2):724-8. PubMed ID: 1985790
[TBL] [Abstract][Full Text] [Related]
3. Intravesical administration of radiolabelled tumour-associated monoclonal antibody in bladder cancer.
Syrigos KN; Khawaja M; Krausz T; Williams G; Epenetos AA
Acta Oncol; 1999; 38(3):379-82. PubMed ID: 10380831
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.
Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Skarlos DV; Dimitriou P; Likourinas M; Zizi A; Proukakis C
Eur J Nucl Med; 1995 Jan; 22(1):25-31. PubMed ID: 7698151
[TBL] [Abstract][Full Text] [Related]
5. Intravesical administration of tumor-associated monoclonal antibody AUA1 in transitional cell carcinoma of the bladder: a study of biodistribution.
Zorzos J; Skarlos DV; Epenetos AA; Pectasides D; Koutsioumba P; Elemenoglou J; Bakiras A; Likourinas M; Dimopoulos K
Urol Res; 1993; 21(6):435-8. PubMed ID: 8171767
[TBL] [Abstract][Full Text] [Related]
6. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
[TBL] [Abstract][Full Text] [Related]
7. Targeting of bladder cancer with monoclonal antibody NCRC48--a possible approach for intravesical therapy.
Kunkler RB; Bishop MC; Green DJ; Pimm MV; Price MR; Frier M
Br J Urol; 1995 Jul; 76(1):81-6. PubMed ID: 7648066
[TBL] [Abstract][Full Text] [Related]
8. Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.
Hughes OD; Bishop MC; Perkins AC; Wastie ML; Denton G; Price MR; Frier M; Denley H; Rutherford R; Schubiger PA
J Clin Oncol; 2000 Jan; 18(2):363-70. PubMed ID: 10637251
[TBL] [Abstract][Full Text] [Related]
9. Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma.
Fazel J; Rötzer S; Seidl C; Feuerecker B; Autenrieth M; Weirich G; Bruchertseifer F; Morgenstern A; Senekowitsch-Schmidtke R
Cancer Biol Ther; 2015; 16(10):1526-34. PubMed ID: 26177233
[TBL] [Abstract][Full Text] [Related]
10. Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladder.
Zorzos J; Skarlos DV; Pozatzidou P; Zizi A; Bakiras A; Koritsiadis S; Pectasidis D; Koutsioumba P; Epenetos AA; Likourinas M
Urol Res; 1994; 22(5):323-7. PubMed ID: 7879319
[TBL] [Abstract][Full Text] [Related]
11. Copper-67 as a therapeutic nuclide for radioimmunotherapy.
Novak-Hofer I; Schubiger PA
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):821-30. PubMed ID: 12029558
[TBL] [Abstract][Full Text] [Related]
12. Preclinical studies of monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer.
Russell PJ; Davis K; Kingsley E; Humphreys J; Hanley J; O'Grady H; Pearce N
Cell Biophys; 1994; 24-25():155-61. PubMed ID: 7736520
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer.
Hughes OD; Bishop MC; Perkins AC; Frier M; Price MR; Denton G; Smith A; Rutherford R; Schubiger PA
Eur J Nucl Med; 1997 Apr; 24(4):439-43. PubMed ID: 9096097
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer.
Russell PJ; Plomley J; Shon IH; O'Grady H; Pearce N
Cell Biophys; 1993; 22(1-3):27-47. PubMed ID: 7889541
[TBL] [Abstract][Full Text] [Related]
15. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer.
Murray A; Simms MS; Scholfield DP; Vincent RM; Denton G; Bishop MC; Price MR; Perkins AC
J Nucl Med; 2001 May; 42(5):726-32. PubMed ID: 11337567
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of Evans blue in an orthotopic AY-27 rat bladder urothelial cell carcinoma model: implication for the improved diagnosis of non-muscle-invasive bladder cancer (NMIBC) using dye-guided white-light cystoscopy.
Elsen S; Lerut E; Van Cleynenbreugel B; van der Aa F; van Poppel H; de Witte PA
BJU Int; 2015 Sep; 116(3):468-77. PubMed ID: 25754262
[TBL] [Abstract][Full Text] [Related]
18. Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats. A model for intravesical radioimmunotherapy.
Russell PJ; Ho Shon I; Boniface GR; Izard ME; Philips J; Raghavan D; Walker KZ
Urol Res; 1991; 19(4):207-13. PubMed ID: 1926654
[TBL] [Abstract][Full Text] [Related]
19. Immunotargeting of urothelial cell carcinoma with intravesically administered Tc-99m labeled HMFG1 monoclonal antibody.
Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Sivolapenko G; Skarlos DV; Serefoglou A; Lykourinas M; Proukakis C
Cell Biophys; 1994; 24-25():75-81. PubMed ID: 7736542
[TBL] [Abstract][Full Text] [Related]
20. [Intravesical radioimmunotherapy of carcinoma in situ of the urinary bladder after BCG failure].
Autenrieth ME; Horn T; Kurtz F; Nguyen K; Morgenstern A; Bruchertseifer F; Schwaiger M; Blechert M; Seidl C; Senekowitsch-Schmidtke R; Gschwend JE; Scheidhauer K
Urologe A; 2017 Jan; 56(1):40-43. PubMed ID: 27885456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
